Financial Performance - The company's revenue for Q3 2021 reached ¥2,489,395,690.22, representing a 40.22% increase compared to the same period last year[3]. - Net profit attributable to shareholders was ¥141,637,061.98, an increase of 8.78% year-on-year, while net profit for the year-to-date decreased by 25.64% to ¥493,796,157.04[3]. - The company reported a basic earnings per share of ¥0.5222, up 8.79% from the previous year, but down 25.64% year-to-date[3]. - The total operating revenue for Q3 2021 was CNY 6,638,953,683.98, an increase of 25% compared to CNY 5,311,976,390.53 in the same period last year[20]. - The net profit for Q3 2021 was CNY 491,658,011.86, a decrease of 27% from CNY 674,033,190.37 in the previous year[21]. - The total comprehensive income attributable to the parent company was CNY 493,796,157.04, a decrease from CNY 664,040,508.73 in the previous period[22]. - Basic and diluted earnings per share were both CNY 1.8204, down from CNY 2.4481 in the previous period[22]. Assets and Liabilities - Total assets at the end of Q3 2021 were ¥9,016,449,248.15, a 65.09% increase from the end of the previous year[4]. - The company's total liabilities increased by 64.87% to ¥1,107,893,024.15 due to business growth and increased working capital loans[9]. - The total liabilities increased to CNY 3,959,980,755.39, up from CNY 2,247,056,507.87, representing a 76% rise year-over-year[18]. - The total equity attributable to shareholders of the parent company was CNY 3,507,350,833.87, compared to CNY 3,097,676,009.27, reflecting a growth of 13%[19]. - The company reported a total owner's equity of CNY 3,097,676,009.27 attributable to the parent company[29]. Cash Flow - The company’s cash flow from operating activities for the year-to-date was ¥424,223,456.90, reflecting a 10.96% increase[3]. - Net cash flow from operating activities was CNY 424,223,456.90, an increase from CNY 382,319,805.64 in the previous period[25]. - Cash inflow from operating activities totaled CNY 5,770,253,713.18, slightly down from CNY 5,793,758,455.73 in the previous period[25]. - Cash outflow from operating activities was CNY 5,346,030,256.28, compared to CNY 5,411,438,650.09 in the previous period[25]. - The net cash flow from investing activities decreased by 93.08% to -632,704,368.30 CNY due to increased cash payments for investments and acquisitions[11]. - Cash flow from financing activities generated a net inflow of CNY 595,904,075.24, up from CNY 229,167,521.07 in the previous period[25]. Inventory and Expenses - The company’s inventory rose by 44.85% to ¥1,944,461,918.68, attributed to increased sales revenue and the consolidation of Dongbao Biological[8]. - The total operating costs amounted to CNY 5,982,077,441.62, up from CNY 4,503,865,898.92, reflecting a 33% increase year-over-year[20]. - Research and development expenses for the quarter were CNY 190,433,020.13, compared to CNY 173,100,886.72 in the same period last year, showing an increase of 10%[20]. - The company’s financial expenses increased by 35.91% to ¥35,506,329.32, primarily due to higher loan interest[10]. Shareholder Information - As of September 30, 2021, the total number of ordinary shareholders was 28,842, with the largest shareholder, Wang Aiguo, holding 46.45% of the shares[13]. - Wang Aiguo directly holds 126,000,000 shares, with 94,500,000 shares pledged[13]. - The company transferred a total of 60% of Yiqing Bio's shares to Dongbao Bio, with the company holding 32% post-transfer[15]. Government Support and Future Plans - The company received government subsidies totaling ¥13,440,992.38, a 55.32% increase compared to the previous year[10]. - The company plans to optimize the engineering technology plan and product structure of its collagen peptide nutritional supplement project[15]. - The company has indicated plans for market expansion and new product development, although specific figures were not disclosed in the report[20]. - The company’s subsidiary, Dongbao Bio, is adjusting part of its fundraising project and reallocating funds to enhance operational efficiency[15]. Miscellaneous - The company has implemented new leasing standards effective from January 1, 2021, impacting financial statement adjustments[30]. - The third quarter report was not audited, indicating preliminary financial data[31].
国恩股份(002768) - 2021 Q3 - 季度财报